Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.
Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis with £6.3m Series A funding round.
Oxford Brain Diagnostics sets out with the goal of improving the treatment of Alzheimer’s by enabling early and accurate detection
The Oxford University spinout company launches to look inside the brain for novel markers of disease.
The visual data exploration company charges up for next stage of its evolution.
Virology spinout Theolytics emerges from stealth with £2.5m seed and Dr Ken Powell as chair.
Samsung’s investment will enable Oxford Semantics to bring its powerful data integration and reasoning engine to more clients.
The virtual reality for mental health spinout partners the Chinese University of Hong Kong and AXA Hong Kong in pilot programme.